IFLScience on MSN
World first trial to reprogram broken cells in glaucoma begins in humans – but is it just hype?
What would you give to be young again? For many, it’s the ultimate dream – one which, with an exciting and controversial new ...
Test time has arrived: the first person has been treated in a highly anticipated gene therapy trial that aims to coax aged ...
Now he has a company that is trying to change the way we think about the so-called dark genome or noncoding DNA. Previously ...
Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created ...
Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in pancreatic cancer—and identified a promising strategy to overcome that resistance.
Researchers at Tianjin First Central Hospital took fat cells from the woman who had been living with Type 1 diabetes for over ...
Leuven, 11 March 2025 – Solid tumors often provide a challenging environment for the T cells of our immune system. By reprogramming the metabolism of T cells, scientists at the VIB-KU Leuven Center ...
A team led by researchers at the University of Toronto has discovered that a group of cells located in the skin and other areas of the body, called neural crest stem cells, are the source of ...
Reprogram Biosciences, a preclinical oncology biotechnology company developing mRNA-based therapeutics to treat solid tumors, today announced the close of its seed financing. The close brings total ...
Researchers from National Taiwan University (NTU) and National Taiwan University Hospital (NTUH) have identified a promising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results